Treatment for Beta-Hemolytic Group C Streptococcus with Amoxicillin Allergy
For a patient with Group C beta-hemolytic streptococcus infection who is allergic to amoxicillin, treat with clindamycin 7 mg/kg/dose three times daily (maximum 300 mg/dose) for 10 days, or alternatively azithromycin 12 mg/kg once daily (maximum 500 mg) for 5 days.
Rationale and Evidence
While the provided guidelines specifically address Group A streptococcal pharyngitis 1, 2, Group C beta-hemolytic streptococci share similar antimicrobial susceptibility patterns and clinical management approaches with Group A streptococci 3, 4, 5.
First-Line Treatment Considerations
Penicillin remains the drug of choice for Group C streptococcal infections 3, but since your patient has an amoxicillin allergy (and amoxicillin is a penicillin derivative), penicillin-class antibiotics must be avoided 6.
Appropriate Alternatives for Penicillin Allergy
The IDSA guidelines for Group A streptococcal pharyngitis provide clear alternatives for penicillin-allergic patients that apply equally to Group C infections 1:
For non-immediate hypersensitivity reactions:
- First-generation cephalosporins (cephalexin 20 mg/kg/dose twice daily, maximum 500 mg/dose, for 10 days) are acceptable 1
- However, avoid cephalosporins if the patient has a history of immediate-type hypersensitivity (anaphylaxis, urticaria, angioedema) to penicillin 1
For any penicillin allergy (including immediate reactions):
- Clindamycin 7 mg/kg/dose three times daily (maximum 300 mg/dose) for 10 days 1 - Strong recommendation, moderate quality evidence
- Azithromycin 12 mg/kg once daily (maximum 500 mg) for 5 days 1 - Strong recommendation, moderate quality evidence
- Clarithromycin 7.5 mg/kg/dose twice daily (maximum 250 mg/dose) for 10 days 1 - Strong recommendation, moderate quality evidence
Critical Decision Points
Type of Allergic Reaction Matters
Determine the nature of the amoxicillin allergy:
- If the patient had a non-immediate reaction (e.g., delayed rash without systemic symptoms), first-generation cephalosporins are safe and effective 1
- If the patient had an immediate hypersensitivity reaction (anaphylaxis, severe urticaria, angioedema within hours of administration), avoid all beta-lactams including cephalosporins 1, 6
Macrolide Resistance Concerns
Important caveat: Resistance of beta-hemolytic streptococci to macrolides (azithromycin, clarithromycin) is well-documented and varies geographically and temporally 1. Research shows that while macrolide resistance in Group A streptococci remains <5% in the United States 7, similar patterns exist for Group C streptococci 5. However, this resistance is emerging 5.
Clindamycin is generally preferred over macrolides when both are options, as it has better tissue penetration and lower resistance rates, though cross-resistance with erythromycin-resistant strains can occur 1.
Recommended Treatment Algorithm
Clarify allergy history:
- Immediate reaction (anaphylaxis, urticaria, angioedema) → Clindamycin or azithromycin
- Non-immediate reaction (delayed rash) → Cephalexin is acceptable, or use clindamycin/azithromycin
If using non-beta-lactam alternatives:
- First choice: Clindamycin 7 mg/kg/dose TID × 10 days (max 300 mg/dose)
- Second choice: Azithromycin 12 mg/kg once daily × 5 days (max 500 mg)
- Third choice: Clarithromycin 7.5 mg/kg/dose BID × 10 days (max 250 mg/dose)
Complete the full course regardless of symptom improvement to ensure bacterial eradication
Additional Considerations
All beta-hemolytic streptococci, including Group C, remain universally susceptible to penicillin 3, 5, making the allergy particularly relevant to management. Research confirms that Group C streptococci show similar antibiotic susceptibility patterns to Group A, with universal susceptibility to penicillin, amoxicillin, cephalosporins, and linezolid 5.
Symptomatic treatment with analgesics (acetaminophen or NSAIDs) can be added for fever and pain control 1. Avoid aspirin in children 1.